Alpha Teknova, Inc.
TKNONASDAQHealthcareDrug Manufacturers - Specialty & Generic

About Alpha Teknova

Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company’ primary products include pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone831 637 1100
Address
2451 Bert Dr. Hollister, California 95023 United States

Corporate Identifiers

CIK0001850902
CUSIP02080L102
ISINUS02080L1026
EIN94-3368109
SIC2835

Leadership Team & Key Executives

Stephen Gunstream
President, Chief Executive Officer and Director
Matthew C. Lowell
Chief Financial Officer
Damon A. Terrill J.D.
General Counsel, Chief Compliance Officer and Secretary
Jennifer Henry
Senior Vice President of Marketing